About Optobionics
Optobionics is a Healthcare company based in Glen Ellyn (United States) founded in 1990. A device to stimulate damaged retinal cells. Optobionics has raised $24.4 million across 3 funding rounds from investors including Medtronic, Arch Venture Partners and Advanced Technology Ventures. Optobionics offers products and services including Artificial Silicon Retina (ASR) implants. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Optobionics Corporation. Its competitors include Kodiak Sciences, Second Sight and iScience Interventional; 3 of its 3 listed competitors have raised funding.
Company details
Optobionics was founded in 1990 in Glen Ellyn, United States, within the medical device sector focused on retinal implants. An Artificial Silicon Retina microchip, measuring 2 mm in diameter and 25 microns thick with about 5,000 microscopic solar cells, was developed to stimulate damaged retinal cells internally. Visual signals are recreated by these cells and sent to the brain. Operations appear to have ceased, rendering the company non-operational.
- Headquarters Glen Ellyn, United States
- SectorsHealthcare
- Phone•••• ••••
- Website optobionics.com
- Legal Name Optobionics Corporation
- Total Equity Funding$24.4M (USD)
in 3 rounds
- Latest Funding Round$20M (USD), Series B
Dec 2001
- InvestorsMedtronic
& 4 more
Products & Services of Optobionics
Optobionics offers a comprehensive portfolio of products and services, including Artificial Silicon Retina (ASR) implants.
Implants designed to stimulate retina for treating Retinitis Pigmentosa vision loss.
Funding Insights of Optobionics
Optobionics has successfully raised a total of $24.4M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $20 million completed in December 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $24.4M
- Total Rounds 3
- Last Round Series B — $20M
- First Round $750,000
(Jun 1997)
- Investors Count 5
All 3 funding rounds of Optobionics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2001 | $20M | Series B | – | – | |
| Jun 2000 | $4.4M | Series A | – | Alcon | |
| Jun 1997 | $750,000 | Unspecified | – | – |
5 investors in total: 5 institutional.
Investors in Optobionics
Optobionics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Medtronic, Arch Venture Partners and Advanced Technology Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm making investment in early stage startups in the US | atvcapital.com | Menlo Park, United States | ||
Venture capital firm focused on life science companies | 1986 | archventure.com | Chicago, United States | |
US focused venture capital firm | polarispartners.com | Boston, United States | ||
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
| cibavision.com |
Investor details for Optobionics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Optobionics
3 dated milestones of Optobionics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Optobionics is founded.
- Funding First funding round of $750K.
- Funding Latest funding round, Series B, of $20.0M.
Competitors of Optobionics
Optobionics has 3 listed competitors in our database, 3 of them funded. They include Kodiak Sciences, Second Sight and iScience Interventional.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kodiak.com | 2009 | Palo Alto, United States | $35.84M | 112 | Therapeutics for retinal diseases are developed by the company. | |
| secondsight.com | 2000 | Los Angeles, United States | $52.3M | 14 | Implantable visual prosthetics for blind individuals are developed and provided. | |
| iscienceinterventional.com | 1999 | Menlo Park, United States | $36.68M | Microcatheter and imaging technologies for ophthalmic procedures are developed. |
Detailed competitors of Optobionics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as Optobionics (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Optobionics
Optobionics was founded in 1990 and raised its 1st funding round 7 years after it was founded.
Optobionics is headquartered in Glen Ellyn, United States. It is registered at Glen Ellyn, Illinois, United States.
Optobionics is a funded company, having raised a total of $24.4M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $750K, raised on Jun 1997.
Optobionics was founded in 1990 in Glen Ellyn, United States, within the medical device sector focused on retinal implants. An Artificial Silicon Retina microchip, measuring 2 mm in diameter and 25 microns thick with about 5,000 microscopic solar cells, was developed to stimulate damaged retinal cells internally. Visual signals are recreated by these cells and sent to the brain. Operations appear to have ceased, rendering the company non-operational.
Optobionics's top competitors include Kodiak Sciences, Second Sight and iScience Interventional.
Optobionics offers Artificial Silicon Retina (ASR) implants.
Optobionics has 5 investors. Key investors include Medtronic, Arch Venture Partners, Advanced Technology Ventures, Polaris Partners, and Alcon.
Optobionics operates through Optobionics Corporation.